1. Home
  2. DCBO vs HQL Comparison

DCBO vs HQL Comparison

Compare DCBO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$16.38

Market Cap

489.9M

Sector

N/A

ML Signal

HOLD

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$17.83

Market Cap

507.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
HQL
Founded
2016
1992
Country
Canada
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
489.9M
507.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DCBO
HQL
Price
$16.38
$17.83
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$32.00
N/A
AVG Volume (30 Days)
100.0K
108.7K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
N/A
Revenue This Year
$12.89
N/A
Revenue Next Year
$11.44
N/A
P/E Ratio
$22.04
$22.59
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$11.72
52 Week High
$33.69
$17.96

Technical Indicators

Market Signals
Indicator
DCBO
HQL
Relative Strength Index (RSI) 43.91 68.64
Support Level $16.28 $16.40
Resistance Level $20.15 N/A
Average True Range (ATR) 0.82 0.35
MACD -0.09 0.14
Stochastic Oscillator 56.84 93.93

Price Performance

Historical Comparison
DCBO
HQL

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Share on Social Networks: